Previous 10 | Next 10 |
2023-06-07 12:02:37 ET Major market averages were seeking direction during Wednesday's midday session ahead of CPI data and the Fed's policy meeting next week. Tracking individual stocks, Stitch Fix ( NASDAQ: SFIX ) shares rose and Casey's General Stores ( NASDAQ: CASY )...
2023-06-07 09:19:40 ET Ionis Pharmaceuticals ( NASDAQ: IONS ) lost ~6% pre-market Wednesday after announcing plans to offer $500M of senior convertible notes due 2028 in a private placement for institutional investors. The company also intends to give the initial buyers an o...
Ionis announces positive donidalorsen late-stage clinical progress in HAE PR Newswire Two-year treatment with donidalorsen in the Phase 2 open label study resulted in consistent, sustained protection from HAE attacks Completed enrollment in the Phase 3 OASIS-HA...
2023-05-31 11:30:49 ET Summary Tweedy Browne's 13F portfolio value decreased by 2% from $1.88B to $1.84B in Q1 2023, with the number of holdings decreasing from 45 to 44. The largest position is Berkshire Hathaway, accounting for 20% of the portfolio, followed by Alphabet, Johnson...
2023-05-26 15:00:30 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
2023-05-23 08:30:00 ET Summary Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pension and profit-sharing plans, charitable foundations, ...
Ionis to host 2023 virtual Annual Meeting of Stockholders PR Newswire CARLSBAD, Calif. , May 10, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2023 virtual Annual Meeting of Stockholders followed ...
2023-05-04 10:49:30 ET Ionis Pharmaceuticals ( NASDAQ: IONS ) traded flat on Thursday after Citi upgraded the developer of RNA-targeted therapeutics to Neutral from Sell following the company's better-than-expected Q1 2023 results. Carlsbad, California-based biotech reported...
2023-05-03 16:45:02 ET Ionis Pharmaceuticals, Inc. (IONS) Q1 2023 Earnings Conference Call May 03, 2023, 11:30 AM ET Company Participants Wade Walke - SVP, IR Brett Monia - CEO Richard Geary - Chief Development Officer Beth Hougen - CFO Eugene Schneider -...
2023-05-03 07:05:40 ET Ionis Pharmaceuticals press release ( NASDAQ: IONS ): Q1 GAAP EPS of -$0.87 beats by $0.04 . Revenue of $131M (-7.7% Y/Y) beats by $4.12M . "Our first quarter results were in line with our expectations. We generated meaningful revenue whi...
News, Short Squeeze, Breakout and More Instantly...
Ionis Pharmaceuticals Inc. Company Name:
IONS Stock Symbol:
NASDAQ Market:
Ionis Pharmaceuticals Inc. Website:
Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome PR Newswire ION582 showed robust and consistent benefit in communication, cognition and motor function in a broad patient population evaluated with a comprehensive set o...
Ionis to hold second quarter 2024 financial results webcast PR Newswire Webcast scheduled for Thursday, August 1 at 11:30 a.m. Eastern Time CARLSBAD, Calif. , July 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced ...
Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease PR Newswire Zilganersen is the first investigational medicine in clinical development for people with Alexander disease, a rare, life-threatening neurological condition...